MEDIVATION, INC.
MDVN
MDVN was delisted on the 27th of September, 2016.
211 hedge funds and large institutions have $4.58B invested in MEDIVATION, INC. in 2013 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 63 increasing their positions, 77 reducing their positions, and 43 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
9% more capital invested
Capital invested by funds: $4.19B → $4.58B (+$391M)
2% more funds holding
Funds holding: 207 → 211 (+4)
9% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 43
18% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 77
33% less call options, than puts
Call options by funds: $80M | Put options by funds: $119M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$122M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$108M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$55.4M |
| 4 |
O
OrbiMed
New York
|
+$50.7M |
| 5 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$36.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$119M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$50.8M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$37.8M |
| 4 |
D.E. Shaw & Co
New York
|
-$37.5M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$35.1M |
MDVN Hedge Fund Activity: Q4 2013 in Review
211 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in MEDIVATION, INC. (MDVN) for Q4 2013, worth a combined $4.58B — up 9.3% from $4.19B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new MDVN positions and 43 closed out — a net gain of 4 holders — while 63 added to existing stakes and 77 trimmed.
The largest buyer was PFM Health Sciences, adding an estimated $122M. The largest seller was T. Rowe Price Associates, cutting an estimated $119M.
- 211 institutional investors held MEDIVATION, INC. (MDVN) as of Q4 2013, up from 207 in Q3 2013.
- Funds reported $4.58B of MEDIVATION, INC. stock for Q4 2013, up 9.3% quarter-over-quarter.
- 47 funds opened new MEDIVATION, INC. positions in Q4 2013 and 43 closed out, a net change of +4 holders.
- The largest MEDIVATION, INC. buyer in Q4 2013 was PFM Health Sciences, an estimated $122M added.
- The largest MEDIVATION, INC. seller in Q4 2013 was T. Rowe Price Associates, an estimated $119M sold.
Based on aggregated 13F filings for Q4 2013.